Finance

Lists
Q3 2026 earnings • in 2 days
See details
RADL3:BVMF
Raia Drogasil S/A
R$15.22
0.00%
(0.00) 1D
Oct 30, 5:05:56 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for RADL3...
Open
R$15.18
High
R$15.98
Low
R$14.99
Mkt. cap
26.67B
Avg. vol.
15.23M
Volume
15.92M
P/E ratio
19.09
52-wk high
R$27.01
52-wk low
R$13.50
EPS
R$0.80
Shares outstanding
1.75B
No. of employees
76K
Open
R$15.18
High
R$15.98
Low
R$14.99
Mkt. cap
26.67B
Avg. vol.
15.23M
Volume
15.92M
P/E ratio
19.09
52-wk high
R$27.01
52-wk low
R$13.50
EPS
R$0.80
Shares outstanding
1.75B
No. of employees
76K
News stories
From web sources and news partners
Profile
RD Saúde is the largest drugstore company in Latin America by revenue and market capitalization. With its headquarters in São Paulo, it has more than 3,000 pharmacies in Brazil with a national presence in all 27 states. The company's pharmacies are branded as Raia and Drogasil and are supplied by 14 distribution centers. The company also leads in online audience through its proprietary Raia and Drogasil mobile apps and websites, which accounted for 15.2% of 2023 retail gross revenues according to publicly filed financial statements. The company has 3.614 stores around Brazil. RD Saúde's top 3 competitors include Grupo DPSP, Pague Menos and Farmácias São João. Wikipedia
About Raia Drogasil S/A
CEORenato Cepollina Raduan
Employees75.6K
FoundedNov 10, 2011
Headquarters-
SectorDrug
Websiterdsaude.com.br
Next call in 2 days
Wed, Nov 4, 8:30 AM
Fiscal period
Q3 2026
- / R$0.26
Revenue / Est. (BRL)
- / 12.06B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.26B
12.10B
10.57B
11.06B
Cost of goods sold
7.95B
8.54B
7.17B
7.36B
Cost of revenue
7.95B
8.54B
7.17B
7.36B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58B
2.82B
2.75B
2.85B
Operating expense
2.58B
2.82B
2.94B
2.86B
Total operating expenses
10.53B
11.36B
10.11B
10.22B
Operating income
733.50M
747.67M
456.29M
838.88M
Other non operating income
-46.23M
-62.76M
-28.28M
-48.97M
EBT including unusual items
544.56M
303.18M
126.80M
530.34M
EBT excluding unusual items
427.87M
358.24M
129.38M
512.80M
Income tax expense
82.88M
12.64M
-20.47M
114.08M
Effective tax rate
15.22%
4.17%
-16.14%
21.51%
Other operating expenses
-
-
192.84M
5.72M
Net income
453.97M
304.92M
158.96M
424.54M
Net profit margin
4.03%
2.52%
1.50%
3.84%
Earnings per share
0.24
0.18
0.18
0.21
Interest and investment income
12.87M
-
2.75M
3.44M
Interest expense
-273.30M
-329.34M
-301.14M
-280.37M
Net interest expenses
-260.44M
-329.34M
-298.39M
-276.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
920.95M
1.02B
662.92M
1.05B
Gain or loss from assets sale
8.28M
55.46M
639.00K
48.48M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps